Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Health Care / Hospitals

Releases published in the last 30 days. RSS 0.91 Feed

Page 2 of 5

Better Collaboration between Pharma and Patient Organizations Would Improve Patient Care, Accenture Study Finds
Better Collaboration between Pharma and Patient Organizations Would Improve Patient Care, Accenture Study Finds
8/10/2019 12:56:50 PM
To deliver better patient experiences, pharmaceutical companies should collaborate with nonprofit organizations that provide support services and advocate for patients, according to a new study from Accenture (NYSE: ACN).
Skin Pigmentation as a Sign of Evolution
Skin Pigmentation as a Sign of Evolution
8/10/2019 12:29:35 PM
Skin is universal. Whether it’s light or dark, young or old, its structure is the same from one individual to another... except for two details: its pigmentation and the bacteria that protects it.
Elsevier and LogicStream Health to deliver nurse documentation optimization solutions
Elsevier and LogicStream Health to deliver nurse documentation optimization solutions
8/10/2019 11:25:34 AM
Elsevier, a global information analytics business specializing in science and health, and LogicStream Health, a leading provider of clinical process improvement and control software, will collaborate to meet health systems’ needs for optimizing their nursing practice and documentation.
FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization
FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization
8/8/2019 2:24:13 PM
Today, the U.S. Food and Drug Administration  issued warning letters  notifying four companies that 44 flavored e-liquid and hookah tobacco products do not have the required marketing authorization, and thus cannot be legally sold in the United States.
Italy/Malta/Spain: 121 people including babies and children stranded at sea in searing heat must be allowed to dock
Italy/Malta/Spain: 121 people including babies and children stranded at sea in searing heat must be allowed to dock
8/8/2019 2:14:51 PM
More than 30 children, including two babies, and nearly 90 men and women stranded at sea in searing temperatures, must be immediately allowed to dock, said Amnesty International, as the stand-off between the Italian, Maltese and Spanish authorities and a NGO rescue ship enters its second week.
WHO statement on Yemen
WHO statement on Yemen
8/8/2019 2:10:41 PM
WHO has a zero-tolerance policy against all forms of corruption. WHO’s Office of Internal Oversight Services (IOS) conducted an audit of the Yemen Country Office during the period July to October 2018.
Europe must act now to end preventable deaths in Libya and at sea
Europe must act now to end preventable deaths in Libya and at sea
8/8/2019 1:52:00 PM
By Dr. Joanne Liu, MSF International President On July 25, tragedy once again hit the Mediterranean. An estimated 150  people drowned  whilst fleeing  Libya.
New ‘liquid biopsy’ blood test improves breast cancer diagnostics
New ‘liquid biopsy’ blood test improves breast cancer diagnostics
8/8/2019 11:54:15 AM
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute (TGen) and Mayo Clinic in Arizona.
PGA TOUR’s Brooks Koepka wins Aon Risk Reward Challenge and $1 million
PGA TOUR’s Brooks Koepka wins Aon Risk Reward Challenge and $1 million
8/8/2019 7:11:07 AM
‒ Winning LPGA player will claim her $1 million prize at November’s CME Group Tour Championship ‒ Season-long competition recognizes players who maximize performance on most challenging holes ‒ Watch the highlights of the Aon Risk Reward Challenge here Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, …
“Opt-Out,” an Amazon Best-Selling Book is Free For One More Day (until 08/09/2019)
“Opt-Out,” an Amazon Best-Selling Book is Free For One More Day (until 08/09/2019)
8/8/2019 6:00:00 AM
Best Seller Publishing  announces the release of TJ Ahn’s new book, “Opt-Out: How to Take Back Financial Control of Your Private Clinical Practice Without the Hassle of Insurance Companies.” It will be available for free download in the Amazon Kindle Store for one more day on August 9th.   All across America, doctors are being forced to close due to the steady decline of …
Lehigh Valley Based Executive Brandon Hensinger Introduces Groundbreaking Reproductive Health Technology on 6 Continents
Lehigh Valley Based Executive Brandon Hensinger Introduces Groundbreaking Reproductive Health Technology on 6 Continents
8/7/2019 6:10:31 PM
Brandon Hensinger, Global Vice President of Sales of Yikon Genomics Inc, the US Subsidiary of Shanghai based Yikon Genomics Ltd, has successfully launched an embryo screening technology that uses non-invasive methodologies to help physicians choose healthy embryos for women going through fertility treatments.
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
8/7/2019 2:28:56 PM
• U.S. FDA submission for children planned for 4Q 2019 A pivotal Phase 3 trial evaluating Dupixent®  (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints.
Novartis stands behind Zolgensma® (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy
Novartis stands behind Zolgensma® (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy
8/7/2019 2:22:11 PM
  Today the FDA released a statement addressing data integrity issues with the Biologics License Application (BLA) for Zolgensma® (onasemnogene abeparvovec-xioi).
Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis
Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis
8/7/2019 2:06:39 PM
Pfizer Inc. (NYSE:PFE) announced that the Phase 3  R ivipansel (GMI-1070):  E valuating  S afety,  E fficacy and  T ime to Discharge (RESET) pivotal study did not meet its primary or key secondary efficacy endpoints.
Forxiga label updated in the EU in type-2 diabetes
Forxiga label updated in the EU in type-2 diabetes
8/6/2019 12:52:00 PM
AstraZeneca announced that the European Commission has approved an update to the marketing authorisation for Forxiga (dapagliflozin) to include positive cardiovascular (CV) outcomes and renal data from the Phase III DECLARE-TIMI 58 trial in adults with type-2 diabetes (T2D).
Grant awarded to Honolulu Theatre for Youth
Grant awarded to Honolulu Theatre for Youth
8/6/2019 12:49:36 PM
Kaiser Permanente Hawaii has awarded a $30,000 community benefit grant to Honolulu Theatre for Youth for 3 original theater productions: “SHH,” “Love,” and “The Carp Who Would Not Quit.” The grant will allow HTY to offer performances for underserved students statewide in partnership with Head Start and the Hawaii State Public Library System.
RB partners with Founders Factory as exclusive Hygiene and Home investor
RB partners with Founders Factory as exclusive Hygiene and Home investor
8/6/2019 12:09:56 PM
RB and Founders Factory have launched Founders Factory Hygiene and Home, a joint venture (JV) to discover and develop startups who will transform the lives of consumers and create a cleaner world through cutting edge technology and innovation.
Kappa opioid receptor influences naltrexone’s effects on drinking alcohol
Kappa opioid receptor influences naltrexone’s effects on drinking alcohol
8/6/2019 12:02:02 PM
Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption in heavy drinkers.
Unicel Architectural now offers motorized “smart” integrated louver solution
Unicel Architectural now offers motorized “smart” integrated louver solution
8/6/2019 8:00:00 AM
Montreal, Canada – August 6, 2019 – Unicel Architectural, manufacturer of vision and daylight control solutions, today announced the availability of Vision Control®XS – an advanced, 100 percent wireless and motorized version of its award-winning integrated louvers solution.    Vision Control®XS enables easy and automatic louver operation from a remote control, tablet or …
Manifestations of Integrity in Medical Services
Manifestations of Integrity in Medical Services
8/5/2019 2:42:01 PM
The urgency we sense in the air of hospitals is the oozing passion of medical practitioners. The desire to aid those in need keeps them going. The field of medicine is not simply a business that directs its focus on earning a good living, and Dr.